Stoke Therapeutics
STOK
#5004
Rank
HK$13.74 B
Marketcap
HK$210.15
Share price
-0.45%
Change (1 day)
-7.96%
Change (1 year)

Earnings for Stoke Therapeutics (STOK)

Earnings in 2026 (TTM): -HK$1.91 Billion

According to Stoke Therapeutics's latest financial reports the company's current earnings are HK$28.21 Million. In 2025 the company made an earning of -HK$53.97 Million, an increase over its 2024 earnings that were of -HK$0.7 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Stoke Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$1.91 Billion3427.54%
2025 -HK$53.97 Million-92.26%
2024 -HK$0.7 Billion-15.01%
2023 -HK$0.83 Billion3.59%
2022 -HK$0.8 Billion17.79%
2021 -HK$0.68 Billion64.24%
2020 -HK$0.41 Billion61.62%
2019 -HK$0.26 Billion158.17%
2018 -HK$98.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$1.23 Billion-35.80%๐Ÿ‡บ๐Ÿ‡ธ USA